Stephen Amato BS, MD

Dr. Stephen Amato is a manager within Pfizer Global Product Development and is currently working to drive clinical innovation by leveraging mobile technologies to make clinical trial participation more engaging, informative and less burdensome, while simultaneously increasing the quality of data obtained. Prior to joining the mClinical team, Dr. Amato managed the BlueSky project, a collaboration between Pfizer and IBM tasked with using wearable sensor modalities to develop a remote monitoring platform intended to quantify the motor signs of people with Parkinson’s disease. Dr. Amato received his Ph.D. in Biology from Boston University and held a postdoctoral fellowship performing novel drug target identification and validation at Pfizer.